Over the past decade, the import value of medicaments mixed together for therapeutic use to Thailand has shown variability, with significant growth during specific years. Year-on-year variations highlight periods of both growth and decline, with notable increases in 2014 (27.75%) and 2020 (8.04%), and a decline in 2022 (-6.7%). The compound annual growth rate (CAGR) over the last five years stands at 2.52%. Future forecasts indicate continued moderate growth with a 5-year forecast CAGR of 1.67%, suggesting a stable import market.
Future trends to watch include the impact of global pharmaceutical advancements, regional trade policies, and Thailand's domestic healthcare needs. Monitoring these factors will be critical in assessing future import patterns.
